Helena Pópulo
Molecular Biology · 2012–2013
A researcher in the Science corpus: 2 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 62 citations into it
- Epidemiology — 5 citations into it
Whom Helena Pópulo trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- K. Inoki
- Beth Levine
- Dos D. Sarbassov
- D. Guertin
- R. Loewith
- Siraj M. Ali
- E. Jacinto
- C. Thoreen
- S. Wullschleger
- N. Hay
Who trusts Helena Pópulo overall
Papers from Helena Pópulo's perspective
Ordered by how strongly the researchers Helena Pópulo trusts endorse each paper. Same corpus, a different order for every researcher.
- TSC2 mediates cellular energy response to control cell growth and survival. (Cell)
- Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex (Science)
- Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis. (Cell)
- Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control. (Molecules and Cells)
- TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling (Nature Cell Biology)
- TOR signaling in growth and metabolism. (Cell)
- Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. (Current Biology)
- The TSC1-2 tumor suppressor controls insulin–PI3K signaling via regulation of IRS proteins (Journal of Cell Biology)
- Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. (Cell)
- Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. (Genes & Development)
Their papers
- The mTOR Signalling Pathway in Human Cancer (2012) — 795 citations
- Frequency of TERT promoter mutations in human cancers (2013) — 850 citations